Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial

BACKGROUND: Prompt treatment of malaria attacks with arteminisin-based combination therapy (ACT) is an essential tool for malaria control. A new co-blister tablet of artesunate-mefloquine (AM) with 25 mg/kg mefloquine has been developed for the management of uncomplicated malaria attacks. This non-i...

Descripción completa

Detalles Bibliográficos
Autores principales: CK Tine, Roger, Faye, Babacar, Sylla, Khadime, Ndiaye, Jean L, Ndiaye, Magatte, Sow, Doudou, Lo, Aminata C, Abiola, Annie, Ba, Mamadou C, Gaye, Oumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554515/
https://www.ncbi.nlm.nih.gov/pubmed/23234606
http://dx.doi.org/10.1186/1475-2875-11-416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554515/
https://www.ncbi.nlm.nih.gov/pubmed/23234606
http://dx.doi.org/10.1186/1475-2875-11-416

Ejemplares similares